中韩卒中血脂专家论坛-关于降脂人群分层 各国共识指南 未来发展趋势

医脉通 2022.09.07

安进·安e学

11条内容

微信图片_20220907114422_03.jpg微信图片_20220907114422_05.jpg微信图片_20220907114422_07.jpg微信图片_20220907114422_09.jpg微信图片_20220907114422_11.jpg微信图片_20220907114422_13.jpg微信图片_20220907114422_14.jpg

参考文献:

1.Mach F, Baigent C, Catapano A L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk[J]. Atherosclerosis, 2019, 290: 140-205. DOI : 10.1093/eurheartj/ehz455.

2.Gil-Núñez A, Masjuan J, Montaner J, et al. Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance[J]. Neurología (English Edition), 2022, 37(2): 136-150.